Web-based information and support for patients with a newly diagnosed neuroendocrine tumor: a feasibility study

Grietje Bouma, Lotte D de Hosson, Claudia E van Woerkom, Hennie van Essen, Geertruida H de Bock, Jolien M Admiraal, Anna K L Reyners, Annemiek M E Walenkamp, Grietje Bouma, Lotte D de Hosson, Claudia E van Woerkom, Hennie van Essen, Geertruida H de Bock, Jolien M Admiraal, Anna K L Reyners, Annemiek M E Walenkamp

Abstract

Purpose: Patients with a neuroendocrine tumor (NET) frequently experience physical and psychosocial complaints. Novel strategies to provide information to optimize supportive care in these patients are of interest. The aim of this study was to examine whether the use of a web-based system consisting of self-screening of problems and care needs, patient education, and self-referral to professional health care is feasible in NET patients and to evaluate their opinion on this.

Methods: Newly diagnosed NET patients were randomized between standard care (n = 10) or intervention with additional access to the web-based system (n = 10) during 12 weeks. Patients completed questionnaires regarding received information, distress, quality of life (QoL), and empowerment. The intervention group completed a semi-structured interview to assess patients' opinion on the web-based system.

Results: The participation rate was 77% (20/26 invited patients) with no dropouts. The use of the web-based system had a negative effect on patients' perception and satisfaction of received information (range Cohen's d -0.88 to 0.13). Positive effects were found for distress (Cohen's d 0.75), global QoL (subscale European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30, Cohen's d 0.46), resolving problems with social functioning and finding information (subscales EORTC QLQ-GINET 21, Cohen's d 0.69, respectively, 1.04), and feeling informed (subscale empowerment questionnaire, Cohen's d 0.51). The interview indicated that the web-based system was of additional value to standard care.

Conclusions: Use of this web-based system is feasible. Contradictory effects on informing and supporting NET patients were found and should be subject of further research.

Trial registration: NCT01849523.

Keywords: Information; Internet; Neuroendocrine tumor; Support; Web-based.

Conflict of interest statement

Conflict of interest

This study was supported by an educational grant of Ipsen to the institute. The sponsor had no involvement in any part of the study. All primary data are in control of the authors and are allowed to be reviewed by the journal if necessary.

References

    1. Oberg KE. The management of neuroendocrine tumours: current and future medical therapy options. Clin Oncol. 2012;24:282–293. doi: 10.1016/j.clon.2011.08.006.
    1. Ramage JK, Ahmed A, Ardill J, Bax N, Breen DJ, Caplin ME, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs) Gut. 2012;61:6–32. doi: 10.1136/gutjnl-2011-300831.
    1. Tuinman MA, Gazendam-Donofrio SM, Hoekstra-Weebers JE. Screening and referral for psychosocial distress in oncologic practice: use of the Distress Thermometer. Cancer. 2008;113:870–878. doi: 10.1002/cncr.23622.
    1. Frojd C, Larsson G, Lampic C, von Essen L. Health related quality of life and psychosocial function among patients with carcinoid tumours. a longitudinal, prospective, and comparative study. Health Qual Life Outcomes. 2007;5:18. doi: 10.1186/1477-7525-5-18.
    1. Haugland T, Vatn MH, Veenstra M, Wahl AK, Natvig GK. Health related quality of life in patients with neuroendocrine tumors compared with the general Norwegian population. Qual Life Res. 2009;18:719–726. doi: 10.1007/s11136-009-9487-x.
    1. Husson O, Mols F, van de Poll-Franse LV. The relation between information provision and health-related quality of life, anxiety and depression among cancer survivors: a systematic review. Ann Oncol. 2011;22:761–772. doi: 10.1093/annonc/mdq413.
    1. Davies NJ, Kinman G, Thomas RJ, Bailey T. Information satisfaction in breast and prostate cancer patients: implications for quality of life. Psychooncology. 2008;17:1048–1052. doi: 10.1002/pon.1305.
    1. Cox A, Jenkins V, Catt S, Langridge C, Fallowfield L. Information needs and experiences: an audit of UK cancer patients. Eur J Oncol Nurs. 2006;10:263–272. doi: 10.1016/j.ejon.2005.10.007.
    1. Mallinger JB, Griggs JJ, Shields CG. Patient-centered care and breast cancer survivors' satisfaction with information. Patient Educ Couns. 2005;57:342–349. doi: 10.1016/j.pec.2004.09.009.
    1. Rehnberg G, Absetz P, Aro AR. Women's satisfaction with information at breast biopsy in breast cancer screening. Patient Educ Couns. 2001;42:1–8. doi: 10.1016/S0738-3991(99)00118-4.
    1. van Uden-Kraan CF, Drossaert CH, Taal E, Shaw BR, Seydel ER, van de Laar MA. Empowering processes and outcomes of participation in online support groups for patients with breast cancer, arthritis, or fibromyalgia. Qual Health Res. 2008;18:405–417. doi: 10.1177/1049732307313429.
    1. Samoocha D, Bruinvels DJ, Elbers NA, Anema JR, van der Beek AJ. Effectiveness of webbased interventions on patient empowerment: a systematic review and meta-analysis. J Med Internet Res. 2010;12:e23. doi: 10.2196/jmir.1286.
    1. Bouma G, Admiraal JM, de Vries EG, Schroder CP, Walenkamp AM, Reyners AK. Internetbased support programs to alleviate psychosocial and physical symptoms in cancer patients: a literature analysis. Crit Rev Oncol Hematol. 2015;95:26–37. doi: 10.1016/j.critrevonc.2015.01.011.
    1. Stichting NET-groep informatie over neuro-endocriene kanker. Available at:
    1. Arraras JI, Greimel E, Sezer O, Chie WC, Bergenmar M, Costantini A, et al. An international validation study of the EORTC QLQ-INFO25 questionnaire: an instrument to assess the information given to cancer patients. Eur J Cancer. 2010;46:2726–2738. doi: 10.1016/j.ejca.2010.06.118.
    1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376. doi: 10.1093/jnci/85.5.365.
    1. Yadegarfar G, Friend L, Jones L, Plum LM, Ardill J, Taal B, et al. Validation of the EORTC QLQGINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours. Br J Cancer. 2013;108:301–310. doi: 10.1038/bjc.2012.560.
    1. van Uden-Kraan CF, Drossaert CH, Taal E, Seydel ER, van de Laar MA. Participation in online patient support groups endorses patients' empowerment. Patient Educ Couns. 2009;74:61–69. doi: 10.1016/j.pec.2008.07.044.
    1. Manuals EORTC. Available at: . Accessed October 1, 2015
    1. European Commission. Available at: . Accessed January 21, 2016
    1. Lepore SJ, Buzaglo JS, Lieberman MA, Golant M, Greener JR, Davey A. Comparing standard versus prosocial internet support groups for patients with breast cancer: a randomized controlled trial of the helper therapy principle. J Clin Oncol. 2014;32:4081–4086. doi: 10.1200/JCO.2014.57.0093.
    1. van de Poll-Franse LV, van Eenbergen MC. Internet use by cancer survivors: current use and future wishes. Support Care Cancer. 2008;16:1189–1195. doi: 10.1007/s00520-008-0419-z.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться